Dr. Michael Everett Manning, MD

Dr. Manning practices at Allergy, Asthma & Immunology Associates Ltd in Scottsdale, Arizona.

Dr. Manning's NPI, 1396744249, was assigned on July 21, 2005. Dr. Manning graduated from McGovern Medical School in 1986. Dr. Manning holds Arizona license 17209.

Dr. Manning's primary practice is Allergy, Asthma & Immunology Associates Ltd, at 7514 E Monterey Way, Scottsdale, AZ 85251 in Maricopa County. The practice phone is (480) 949-7377.

Dr. Manning's primary practice is Allergy, Asthma & Immunology Associates Ltd in Scottsdale, Arizona. Dr. Manning is also affiliated with HonorHealth John C. Lincoln Medical Center. The medical group on file is Allergy, Asthma & Immunology Associates, LTD. Dmand AI also links Dr. Manning to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manning practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Manning's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Manning is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Manning's licenses on file in 3 states: Arizona, Texas and California.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Manning treats.

CMS data shows 87,435 Medicare services from Dr. Manning across 26 procedure codes in 2024, for 1,074 Medicare patients. Medicare paid $2,376,053 for them. Every service was in an office.

CMS counts 1,074 Medicare patients who saw Dr. Manning in 2024. The largest group is 65 to 74, with 542 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manning's median patient age at 62, with 63% women.

In 2024, Dr. Manning wrote 2,188 Medicare Part D claims for 372 patients. 58% of them were for generic drugs. CMS names the drug for 1,850 of them, across 40 drugs with 11 or more claims each, at $8,319,515 in total drug cost. In 2023, CMS named 1,835 claims across 44 drugs.

Dr. Manning accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manning as offering telehealth.

Dmand AI links 12 papers to Dr. Manning, published from 2018 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Angioedemas, Hereditary, Complement C1 Inhibitor Protein and Prekallikrein. Dr. Manning has published most often in Allergy Asthma Clin Immunol. Dr. Manning's most frequent co-authors are Jonathan A. Bernstein, MD, Timothy J. Craig, DO and William Raymond Lumry, MD.

Dmand AI links Dr. Manning to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hereditary Complement Deficiency Diseases and Angioedemas, Hereditary. Open Payments lists research payments to Dr. Manning that name 3 trials.

CMS Open Payments shows 2,741 general payments to Dr. Manning from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Shire North American Group Inc paid the most, $471,107. It also lists 33 research payments totaling $36,111 from 2016 to 2025, naming 3 clinical trials.

Dmand AI lists 5 awards for Dr. Manning, most recently CMS Stage 1 EHR in 2013.

Dr. Manning graduated from McGovern Medical School in 1986. Dr. Manning is a member of AAAAI and ACP.

Dr. Manning is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.